Fred Alger Management LLC Sells 820,421 Shares of ACADIA Pharmaceuticals Inc.

The firm now owns 1,567,035 shares of the biopharmaceutical company's stock.

Mar. 16, 2026 at 10:18am

Got story updates? Submit your updates here. ›

Fred Alger Management LLC lowered its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) by 34.4% during the third quarter, according to the company's recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm now owns 1,567,035 shares of the biopharmaceutical company's stock, worth $33,441,000 at the end of the quarter.

Why it matters

This filing provides insight into the investment activities of Fred Alger Management LLC, a prominent institutional investor, and their changing position in ACADIA Pharmaceuticals, a biopharmaceutical company focused on central nervous system disorders.

The details

According to the 13F filing, Fred Alger Management LLC sold 820,421 shares of ACADIA Pharmaceuticals during the third quarter, reducing their stake in the company by 34.4%. The firm now owns 1,567,035 shares, or 0.93% of the company's outstanding stock, valued at $33,441,000 as of the end of the quarter.

  • The filing covers the third quarter of the year.
  • The shares were sold during the third quarter.

The players

Fred Alger Management LLC

An investment management firm that lowered its holdings in ACADIA Pharmaceuticals Inc. during the third quarter.

ACADIA Pharmaceuticals Inc.

A biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system disorders.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the changing investment strategies of institutional investors like Fred Alger Management LLC and provides insight into the market's perception of ACADIA Pharmaceuticals as the company continues to develop its pipeline of central nervous system disorder treatments.